CS
Chris Schott JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
9.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
85.7%
Neutral
7.1%
Negative
7.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $1,150 |
13%
upside
| 2 | +17% |
0
%
| 18 Nov ‘25 16 days ago |
|
|
|
Underweight
Maintained
| $12 |
65%
upside
| 1 | +6.1% |
0
%
| 11 Nov ‘25 23 days ago |
|
|
|
Overweight
Maintained
| $28 |
1%
downside
| 2 | +19% |
0
%
| 6 Nov ‘25 28 days ago |
|
|
|
Neutral
Downgraded
| $20 |
48%
upside
| 1 | -36% |
0
%
| 6 Nov ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $200 |
66%
upside
| 1 | -3.1% |
0
%
| 5 Nov ‘25 29 days ago |
|
|
|
Overweight
Maintained
| $775 |
8%
upside
| 1 | +17% |
0
%
| 4 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $260 |
14%
upside
| 2 | +2.4% |
0
%
| 3 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $150 |
21%
upside
| 2 | +5.8% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Upgraded
| $24 |
10%
upside
| 1 | +6.1% |
0
%
| 7 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $14 |
17%
upside
| 1 | +24% |
0
%
| 16 Sep ‘25 2 months ago |
|